Akebia Therapeutics, Inc. (AKBA)
1.02
+0.01
(+0.99%)
USD |
NASDAQ |
May 21, 16:00
1.02
0.00 (0.00%)
After-Hours: 05:52
Akebia Therapeutics Research and Development Expense (TTM) : 66.13M for March 31, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Ionis Pharmaceuticals, Inc. | 923.53M |
| MannKind Corp. | 72.56M |
| United Therapeutics Corp. | 539.20M |
| Ardelyx, Inc. | 73.40M |
| Rhythm Pharmaceuticals, Inc. | 171.76M |